Identification of a Residue in Hepatitis C Virus E2 Glycoprotein That Determines Scavenger Receptor BI and CD81 Receptor Dependency and Sensitivity to Neutralizing Antibodies
暂无分享,去创建一个
Jin Zhong | Joe Grove | Peter Balfe | J. McKeating | J. Grove | P. Balfe | H. Drummer | Jin Zhong | M. Bassendine | Heidi E. Drummer | Søren Nielsen | Margaret F. Bassendine | Jane A. McKeating | S. Nielsen
[1] J. Sodroski,et al. Identification and characterization of monoclonal antibodies specific for polymorphic antigenic determinants within the V2 region of the human immunodeficiency virus type 1 envelope glycoprotein , 1995, Journal of virology.
[2] B. Bartosch,et al. Infectious Hepatitis C Virus Pseudo-particles Containing Functional E1–E2 Envelope Protein Complexes , 2003, The Journal of experimental medicine.
[3] D. Adams,et al. Immunopathology and Infectious Diseases Expression of DC-SIGN and DC-SIGNR on Human Sinusoidal Endothelium A Role for Capturing Hepatitis C Virus Particles , 2006 .
[4] S. Wünschmann,et al. Characterization of Hepatitis C Virus (HCV) and HCV E2 Interactions with CD81 and the Low-Density Lipoprotein Receptor , 2000, Journal of Virology.
[5] D. Lavillette,et al. Characterization of host‐range and cell entry properties of the major genotypes and subtypes of hepatitis C virus , 2005, Hepatology.
[6] F. Chisari,et al. Cellular Determinants of Hepatitis C Virus Assembly, Maturation, Degradation, and Secretion , 2007, Journal of Virology.
[7] Ralf Bartenschlager,et al. High Density Lipoprotein Inhibits Hepatitis C Virus-neutralizing Antibodies by Stimulating Cell Entry via Activation of the Scavenger Receptor BI* , 2006, Journal of Biological Chemistry.
[8] M. Kieny,et al. Entry of hepatitis C virus pseudotypes into primary human hepatocytes by clathrin-dependent endocytosis. , 2006, The Journal of general virology.
[9] R. Bartenschlager,et al. Production of infectious hepatitis C virus in tissue culture from a cloned viral genome , 2005, Nature Medicine.
[10] M. Gale,et al. Hepatitis C virus production by human hepatocytes dependent on assembly and secretion of very low-density lipoproteins , 2007, Proceedings of the National Academy of Sciences.
[11] A. Maerz,et al. A Conserved Gly436-Trp-Leu-Ala-Gly-Leu-Phe-Tyr Motif in Hepatitis C Virus Glycoprotein E2 Is a Determinant of CD81 Binding and Viral Entry , 2006, Journal of Virology.
[12] C. Rice,et al. Hepatitis C Virus Entry* , 2008, Journal of Biological Chemistry.
[13] Broadly neutralizing human monoclonal antibodies to the hepatitis C virus E2 glycoprotein , 2008, The Journal of general virology.
[14] H. Drummer,et al. Determinants of CD81 dimerization and interaction with hepatitis C virus glycoprotein E2. , 2005, Biochemical and Biophysical Research Communications - BBRC.
[15] Q. Sattentau,et al. Conformational changes induced in the envelope glycoproteins of the human and simian immunodeficiency viruses by soluble receptor binding , 1993, Journal of virology.
[16] E. Blanchard,et al. Hepatitis C Virus Entry Depends on Clathrin-Mediated Endocytosis , 2006, Journal of Virology.
[17] Z. Keck,et al. Immunogenic and Functional Organization of Hepatitis C Virus (HCV) Glycoprotein E2 on Infectious HCV Virions , 2006, Journal of Virology.
[18] R. Thomssen,et al. Association of hepatitis C virus in human sera with beta-lipoprotein. , 1992, Medical microbiology and immunology.
[19] L. Seeff,et al. Natural history of hepatitis C , 1997, Hepatology.
[20] A. Tarr,et al. Identification of Conserved Residues in the E2 Envelope Glycoprotein of the Hepatitis C Virus That Are Critical for CD81 Binding , 2006, Journal of Virology.
[21] S. Levy,et al. CD81 (TAPA-1): a molecule involved in signal transduction and cell adhesion in the immune system. , 1998, Annual review of immunology.
[22] R. Doms,et al. Hepatitis C Virus Glycoproteins Interact with DC-SIGN and DC-SIGNR , 2003, Journal of Virology.
[23] C. Cheng‐Mayer,et al. Hepatitis C virus glycoproteins mediate pH-dependent cell entry of pseudotyped retroviral particles , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[24] Olga Kalinina,et al. Lipoprotein lipase mediates hepatitis C virus (HCV) cell entry and inhibits HCV infection , 2007, Cellular microbiology.
[25] T. Dragic,et al. Hepatitis C Virus Entry Requires a Critical Postinternalization Step and Delivery to Early Endosomes via Clathrin-Coated Vesicles , 2006, Journal of Virology.
[26] R. Thomssen,et al. Association of hepatitis C virus in human sera with β-lipoprotein , 2004, Medical Microbiology and Immunology.
[27] James S. Owen,et al. Scavenger Receptor BI and BII Expression Levels Modulate Hepatitis C Virus Infectivity , 2007, Journal of Virology.
[28] T L Hoffman,et al. Stable exposure of the coreceptor-binding site in a CD4-independent HIV-1 envelope protein. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[29] William C. Olson,et al. CD4-dependent, antibody-sensitive interactions between HIV-1 and its co-receptor CCR-5 , 1996, Nature.
[30] Jean Dubuisson,et al. High Density Lipoproteins Facilitate Hepatitis C Virus Entry through the Scavenger Receptor Class B Type I* , 2005, Journal of Biological Chemistry.
[31] R. W. Mccollum. The natural history of hepatitis. , 1969, Bulletin of the New York Academy of Medicine.
[32] O. Schwartz,et al. DC-SIGN and L-SIGN Are High Affinity Binding Receptors for Hepatitis C Virus Glycoprotein E2* , 2003, Journal of Biological Chemistry.
[33] L. Corey,et al. Use of the MagNA Pure LC Automated Nucleic Acid Extraction System followed by Real-Time Reverse Transcription-PCR for Ultrasensitive Quantitation of Hepatitis C Virus RNA , 2004, Journal of Clinical Microbiology.
[34] D. Ho,et al. Diverse Hepatitis C Virus Glycoproteins Mediate Viral Infection in a CD81-Dependent Manner , 2004, Journal of Virology.
[35] R. Cortese,et al. The human scavenger receptor class B type I is a novel candidate receptor for the hepatitis C virus , 2002, The EMBO journal.
[36] Joseph Sodroski,et al. CD4-induced interaction of primary HIV-1 gp120 glycoproteins with the chemokine receptor CCR-5 , 1996, Nature.
[37] R. Bartenschlager,et al. The lipid droplet is an important organelle for hepatitis C virus production , 2007, Nature Cell Biology.
[38] Christopher T. Jones,et al. Diverse CD81 Proteins Support Hepatitis C Virus Infection , 2006, Journal of Virology.
[39] A. Burt,et al. Association between Hepatitis C Virus and Very-Low-Density Lipoprotein (VLDL)/LDL Analyzed in Iodixanol Density Gradients , 2006, Journal of Virology.
[40] Y. Tang,et al. Development of a ssRNA internal control template reagent for a multiplex RT-PCR to detect turkey astroviruses. , 2005, Journal of virological methods.
[41] A. Thiele,et al. Density heterogeneities of hepatitis C virus in human sera due to the binding of β-lipoproteins and immunoglobulins , 1993, Medical Microbiology and Immunology.
[42] J. McKeating,et al. Effect of Cell Polarization on Hepatitis C Virus Entry , 2007, Journal of Virology.
[43] D. Silver. SR-BI and Protein-Protein Interactions in Hepatic High Density Lipoprotein Metabolism , 2004, Reviews in Endocrine and Metabolic Disorders.
[44] J. Dubuisson,et al. Early steps of the hepatitis C virus life cycle , 2008, Cellular microbiology.
[45] S. Lemon,et al. Definition of a Conserved Immunodominant Domain on Hepatitis C Virus E2 Glycoprotein by Neutralizing Human Monoclonal Antibodies , 2008, Journal of Virology.
[46] D. Harats,et al. The low-density lipoprotein receptor plays a role in the infection of primary human hepatocytes by hepatitis C virus. , 2007, Journal of hepatology.
[47] M. Houghton,et al. Binding of hepatitis C virus to CD81. , 1998, Science.
[48] B. Chesebro,et al. Effects of CCR5 and CD4 Cell Surface Concentrations on Infections by Macrophagetropic Isolates of Human Immunodeficiency Virus Type 1 , 1998, Journal of Virology.
[49] Christopher T. Jones,et al. University of Birmingham Time-and Temperature-Dependent Activation of Hepatitis C Virus for Low-pH-Triggered Entry , 2006 .
[50] S. Emerson,et al. Advantages of a single-cycle production assay to study cell culture-adaptive mutations of hepatitis C virus , 2008, Proceedings of the National Academy of Sciences.
[51] P. André,et al. Characterization of Low- and Very-Low-Density Hepatitis C Virus RNA-Containing Particles , 2002, Journal of Virology.
[52] B. Manicassamy,et al. Dissecting the role of putative CD81 binding regions of E2 in mediating HCV entry: Putative CD81 binding region 1 is not involved in CD81 binding , 2008, Virology Journal.
[53] C. Blish,et al. Enhancing Exposure of HIV-1 Neutralization Epitopes through Mutations in gp41 , 2008, PLoS medicine.
[54] J. Sodroski,et al. The Level of CD4 Expression Limits Infection of Primary Rhesus Monkey Macrophages by a T-Tropic Simian Immunodeficiency Virus and Macrophagetropic Human Immunodeficiency Viruses , 2000, Journal of Virology.
[55] Robert J. Linhardt,et al. Viral and Cellular Determinants of the Hepatitis C Virus Envelope-Heparan SulfateInteraction , 2006, Journal of Virology.
[56] Charles M. Rice,et al. Claudin-1 is a hepatitis C virus co-receptor required for a late step in entry , 2007, Nature.
[57] R. Bartenschlager,et al. Cell Culture Adaptation of Hepatitis C Virus and In Vivo Viability of an Adapted Variant , 2007, Journal of Virology.
[58] R. Cortese,et al. High-Avidity Monoclonal Antibodies against the Human Scavenger Class B Type I Receptor Efficiently Block Hepatitis C Virus Infection in the Presence of High-Density Lipoprotein , 2007, Journal of Virology.
[59] F. Penin,et al. An Interplay between Hypervariable Region 1 of the Hepatitis C Virus E2 Glycoprotein, the Scavenger Receptor BI, and High-Density Lipoprotein Promotes both Enhancement of Infection and Protection against Neutralizing Antibodies , 2005, Journal of Virology.
[60] C. Rice,et al. Oxidized low‐density lipoprotein inhibits hepatitis C virus cell entry in human hepatoma cells , 2006, Hepatology.
[61] C. Rice,et al. Cell culture-grown hepatitis C virus is infectious in vivo and can be recultured in vitro. , 2006, Proceedings of the National Academy of Sciences of the United States of America.
[62] F. Chisari,et al. Persistent Hepatitis C Virus Infection In Vitro: Coevolution of Virus andHost , 2006, Journal of Virology.
[63] D. Burton,et al. Robust hepatitis C virus infection in vitro. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[64] A. Burt,et al. Characterization of the genome and structural proteins of hepatitis C virus resolved from infected human liver. , 2004, The Journal of general virology.
[65] Robert J. Linhardt,et al. Cellular Binding of Hepatitis C Virus Envelope Glycoprotein E2 Requires Cell Surface Heparan Sulfate* , 2003, Journal of Biological Chemistry.
[66] J. Dubuisson,et al. Serum-Derived Hepatitis C Virus Infection of Primary Human Hepatocytes Is Tetraspanin CD81 Dependent , 2007, Journal of Virology.
[67] S. Sone,et al. The roles of CD81 and glycosaminoglycans in the adsorption and uptake of infectious HCV particles , 2007, Journal of medical virology.
[68] Toshiaki Maruyama,et al. Complete Replication of Hepatitis C Virus in Cell Culture , 2005, Science.
[69] P. Briand,et al. Mutations in the env gene of human immunodeficiency virus type 1 NDK isolates and the use of African green monkey CXCR4 as a co-receptor in COS-7 cells. , 1999, The Journal of general virology.
[70] J. Dubuisson,et al. Characterization of Hepatitis C Virus E2 Glycoprotein Interaction with a Putative Cellular Receptor, CD81 , 1999, Journal of Virology.
[71] Jieyun Jiang,et al. Human Apolipoprotein E Is Required for Infectivity and Production of Hepatitis C Virus in Cell Culture , 2007, Journal of Virology.
[72] B. Bartosch,et al. C-type Lectins L-SIGN and DC-SIGN Capture and Transmit Infectious Hepatitis C Virus Pseudotype Particles* , 2004, Journal of Biological Chemistry.
[73] H. Drummer,et al. Identification of the Hepatitis C Virus E2 Glycoprotein Binding Site on the Large Extracellular Loop of CD81 , 2002, Journal of Virology.
[74] Arvind H. Patel,et al. Analysis of Antigenicity and Topology of E2 Glycoprotein Present on Recombinant Hepatitis C Virus-Like Particles , 2002, Journal of Virology.
[75] S. Lemon,et al. A Point Mutation Leading to Hepatitis C Virus Escape from Neutralization by a Monoclonal Antibody to a Conserved Conformational Epitope , 2008, Journal of Virology.
[76] J. McKeating,et al. Hepatitis C virus cell‐cell transmission in hepatoma cells in the presence of neutralizing antibodies , 2007, Hepatology.
[77] Ursula Andréo,et al. The interaction of natural hepatitis C virus with human scavenger receptor SR‐BI/Cla1 is mediated by ApoB‐containing lipoproteins , 2006, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[78] M. Krieger,et al. Scavenger receptor class B type I is a multiligand HDL receptor that influences diverse physiologic systems. , 2001, The Journal of clinical investigation.
[79] Charles M. Rice,et al. Highly Permissive Cell Lines for Subgenomic and Genomic Hepatitis C Virus RNA Replication , 2002, Journal of Virology.
[80] Ralf Bartenschlager,et al. Scavenger receptor class B type I is a key host factor for hepatitis C virus infection required for an entry step closely linked to CD81 , 2007, Hepatology.
[81] J. McKeating,et al. Hepatitis C virus entry and neutralization. , 2008, Clinics in liver disease.
[82] Thomas Baumert,et al. Cooperativity between Cd81 and Scavenger Dependent on Cholesterol and Initiation of Hepatitis C Virus Infection Is , 2006 .